Quince Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying

Quince Therapeutics 和其他兩隻低於 3 美元的股票內部人士正在買入

Benzinga · 2023/08/14 08:45

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Gaia

The Trade: Gaia, Inc. (NASDAQ:GAIA) Director Paul Sutherland acquired a total of 1,000 shares an average price of $2.57. To acquire these shares, it cost around $2.57 thousand.
What's Happening: Gaia reported a wider-than-expected second-quarter loss.
What Gaia Does: Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels-Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga.

Rise Gold

The Trade: Rise Gold Corp. (OTC:RYES) 10% owner V B S Investments Pty Ltd acquired a total of 500,000 shares at an average price of $0.40. The insider spent around $200,000.
What's Happening: Rise Gold said Mr. Daniel Oliver Jr. has been appointed as a director of the Company.
What Rise Gold Does: Rise Gold Corp is a mineral exploration stage mining company and its primary asset is a major past producing Idaho-Maryland Gold Mine property near Grass Valley, California, United States.

Quince Therapeutics

The Trade: Quince Therapeutics, Inc. (NASDAQ:QNCX) CEO Dirk Thye acquired a total of 88,000 shares at an average price of $1.26. To acquire these shares, it cost around $110,880.
What's Happening: Quince Therapeutics posted a narrower first-quarter loss.
What Quince Therapeutics Does: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases.

Check This Out: Top 5 Materials Stocks You May Want To Dump This Month

Don't forget to check out our premarket coverage here

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五收盤上漲超過100點。當內部人士購買或賣出股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將其視爲其整體投資或交易決策中的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是近期一些值得注意的細價股內幕交易。欲了解更多，請查看 本辛加的內幕交易 平台。

Gaia

蓋亞

The Trade: Gaia, Inc. (NASDAQ:GAIA) Director Paul Sutherland acquired a total of 1,000 shares an average price of $2.57. To acquire these shares, it cost around $2.57 thousand.
What's Happening: Gaia reported a wider-than-expected second-quarter loss.
What Gaia Does: Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels-Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga.

交易： Gaia, Inc. （納斯達克股票代碼：GAIA）董事保羅·薩瑟蘭 共收購了 1,000 股股份 平均價格爲2.57美元。要收購這些股票，需要花費大約2.57萬美元。
發生了什麼： Gaia報告稱，第二季度的虧損幅度超過預期。
Gaia 在做什麼： Gaia Inc是一家視頻流媒體服務和社區，通過主要渠道提供精心策劃的有意識的媒體——Seeking Truth爲當今不斷變化的世界提供了新的啓發性視角；Transformation在精神成長、個人發展和意識擴展等利基領域提供了豐富的內容；另類治療頻道的內容側重於食物和營養、整體治療、替代和綜合藥物、長壽以及瑜伽。

Rise Gold

崛起黃金

The Trade: Rise Gold Corp. (OTC:RYES) 10% owner V B S Investments Pty Ltd acquired a total of 500,000 shares at an average price of $0.40. The insider spent around $200,000.
What's Happening: Rise Gold said Mr. Daniel Oliver Jr. has been appointed as a director of the Company.
What Rise Gold Does: Rise Gold Corp is a mineral exploration stage mining company and its primary asset is a major past producing Idaho-Maryland Gold Mine property near Grass Valley, California, United States.

這筆交易: Rise Gold 公司 (場外交易代碼:RYES) 10% 所有者 V B S Investments Pty Ltd 共收購50萬股股票 平均價格爲0.40美元。知情人士花了大約20萬美元。
發生了什麼: Rise Gold表示，小丹尼爾·奧利弗先生已被任命爲公司董事。
Rise Gold 的作用: Rise Gold Corp. 是一家處於礦產勘探階段的採礦公司，其主要資產是過去在美國加利福尼亞州格拉斯谷附近生產愛達荷州-馬里蘭州金礦物業的主要資產。

Quince Therapeutics

昆斯療法

The Trade: Quince Therapeutics, Inc. (NASDAQ:QNCX) CEO Dirk Thye acquired a total of 88,000 shares at an average price of $1.26. To acquire these shares, it cost around $110,880.
What's Happening: Quince Therapeutics posted a narrower first-quarter loss.
What Quince Therapeutics Does: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases.

這筆交易: Quince Therapeutics, In （納斯達克股票代碼：QNCX）首席執行官 Dirk They 共收購了 88,000 股股票 平均價格爲1.26美元。要收購這些股票，需要花費大約110,880美元。
發生了什麼: Quince Therapeutics公佈的第一季度虧損有所收窄。
Quince Therapeutics: Quince Therapeutics Inc. 是一家臨床前階段的生物製藥公司，專注於推進針對使人衰弱和罕見疾病的創新精準療法。

Check This Out: Top 5 Materials Stocks You May Want To Dump This Month

看看這個： 本月你可能想拋售的五大材料股

Don't forget to check out our premarket coverage here

別忘了在這裏查看我們的上市前報道

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息